Lay Summary
Results from NGM282 drug trial in PSC
Results of another drug trial for PSC have now been published following preliminary results announced last year.
Read MoreResults GS-9674 drug trial in PSC
GS-9674 led to significant improvements in liver biochemistry and markers of cholestasis in PSC patients.
Read MoreThe impact of colectomy type following liver transplant for PSC
Colectomies and PSC transplant: end ileostomy compared to ileal-pouch anal anastomosis (IPAA).
Read MoreResearch begins looking at IBD care after transplant for PSC
First nationwide audit of IBD care delivery following liver transplantation for PSC.
Read MoreNew guidelines for management of liver blood tests
New British Society of Gastroenterology (BSG) Guidelines have now been published.
Read MorePSC Support responds to EMA consultation on behalf of patients
The European Medicines Agency is evaluating clinical trial design in PSC.
Read MoreVAP-1 in PSC: latest findings published
New and exciting findings about the activity of the enzyme, VAP-1.
Read MoreTreatments for PSC and PBC
Update on pharmacotherapies (treatemnts) for cholestatic liver disease.
Read MoreFactors affecting clinical course of PSC
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associated With Course of Primary Sclerosing Cholangitis.
Read MoreUpdate on the genetics of PSC
New discoveries from an international PSC genetic study open the door to new potential drug targets and trials.
Read More